EN
HI
Summary
As of 28 Sep, 2026, Cohance Lifesciences stock price is ₹453.3. During the trading session, the stock has moved between an intraday low of ₹445.00 and an intraday high of ₹459.25. Over the last 52 weeks, Cohance Lifesciences has traded between ₹266.70 and ₹917.85.
The stock has recorded a trading volume of 5,68,862 shares,. Its Average Traded Price (ATP) is ₹452.86, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 26 @ ₹453.30.
Cohance Lifesciences has an upper circuit limit of ₹551.10 and a lower circuit limit of ₹367.40. The total value traded stands at ₹25.76 CR, and the delivery percentage for the day is 74.14%.
The stock is currently traded with a market lot size of 1. Cohance Lifesciences also offers a dividend yield of 0%.
Cohance Lifesciences Share Price Chart
Cohance Lifesciences Share Key Metrics
Volume
5.69 L
Market Cap
17341.77 CR
LTQ@LTP
26@453.30
ATP
452.86
Var Margin
22.46 %
Circuit Range
367.4-551.1
Delivery %
74.14 %
Value
25.76 CR
ASM/GSM
No
Market Lot
1
Cohance Lifesciences Fundamentals
P/E Ratio
165.33
P/B Ratio
4.56
Div. Yield
0
Sector P/E
38.06
Sector P/B
3.64
Sec. Div. Yield
0.51
Cohance Lifesciences Resistance and Support
Pivot 456.43
Resistance
First Resistance
462.81
Second Resistance
466.38
Third Resistance
472.76
Support
First Support
452.86
Second Support
446.48
Third Support
442.91
Cohance Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Sep 28 2026 | 459.25 | 453.3 | -1.30% | 459.25 | 445 |
| Fri Sep 25 2026 | 456.29 | 459.25 | 1.13% | 460 | 450.04 |
| Thu Sep 24 2026 | 459 | 454.14 | -1.58% | 464.45 | 451.1 |
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Cohance Lifesciences News
Cohance Lifesciences Ltd - 543064 - General Upadte
Cohance Lifesciences' API manufacturing facility in Jaggaiahpet, Andhra Pradesh, underwent a USFDA inspection from September 14-19, 2026. The inspection concluded with the issuance of a Form FDA 483 citing five observations. The company is preparing corrective and preventive actions.
Sep 21 2026 11:37:49
Cohance Lifesciences Ltd - 543064 - General Update
Cohance Lifesciences remitted USD 10 million to its US subsidiary NJ Bio Inc. for subscription of new CCPS. This investment supports the ADC-focused CRDMO's growth and capital expenditure, reinforcing Cohance's strategic commitment to the ADC space.
Sep 18 2026 18:34:24
Read More
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Umang Vohra | Chairman |
| Himanshu Agarwal | Whole Time Director |
Cohance Lifesciences Similar Stocks
Astrazeneca Pharma India Ltd.
6280.00
-225.00 (3.46%)
Pfizer Ltd.
3968.00
-32.80 (0.82%)
Onesource Specialty Pharma Ltd.
1565.80
-36.80 (2.30%)
Eris Lifesciences Ltd.
1236.30
-22.60 (1.80%)
Poly Medicure Ltd.
1636.70
-87.70 (5.09%)
Jubilant Pharmova Ltd.
1060.45
-11.50 (1.07%)
Alembic Pharmaceuticals Ltd.
854.35
-9.40 (1.09%)
Dr. Agarwal's Health Care Ltd.
503.60
3.60 (0.72%)
Vijaya Diagnostic Centre Ltd.
1501.40
-12.20 (0.81%)
Concord Biotech Ltd.
1392.70
-60.90 (4.19%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 453.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 165.33. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 4.56. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 38.06 & 3.64 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 17341.77 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 917.85 & 266.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in COHANCE
